Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Viral Syndrome”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT01300988
What this trial is testing

Effects of Treatment With Aprepitant (Emend®) in HIV Infected Individuals. 375 mg Dose

Who this might be right for
HIV Infection
University of Pennsylvania 18
Large-scale testing (Phase 3)Study completedNCT00381303
What this trial is testing

GRACE: A Study to Compare the Effectiveness, Safety and Tolerability of PREZISTA (Darunavir)/Ritonavir by Gender and Race When Administered With Other Antiretroviral Medications in Human Immunodeficiency Virus (HIV) Positive Women and Men.

Who this might be right for
HIVInfectious
Tibotec, Inc 429
Testing effectiveness (Phase 2)Study completedNCT00964327
What this trial is testing

TMC114-C201: A Study to Determine the Antiviral Activity of TMC114 in Patients With Multiple Protease Inhibitor (PI) Resistant Human Immunodeficiency Virus (HIV) Strains

Who this might be right for
HIV Infections
Tibotec Pharmaceuticals, Ireland 42
Not applicableUnknownNCT06348186
What this trial is testing

Fascial Tissue Response to Manual Therapy: Implications in Long COVID-19

Who this might be right for
COVID-19
University of the State of Santa Catarina 30
Not applicableActive Not RecruitingNCT05285670
What this trial is testing

Mobile Phone Messaging to Improve Reproductive Health for Women Living With HIV in Kenya (Mobile WACh Empower)

Who this might be right for
HivContraceptionFertility Issues
University of Washington 3,310
Testing effectiveness (Phase 2)Ended earlyNCT00300573
What this trial is testing

Randomized, Double-Blind Study Comparing Dexelvucitabine (DFC) to Lamivudine (3TC) in Subjects With Resistance to NRTIs, PIs, and NNRTIs

Who this might be right for
HIV InfectionsHuman Immunodeficiency Virus
Incyte Corporation 250
Not applicableUnknownNCT05745805
What this trial is testing

Cohort Follow-up of Epidemic and Neuroimaging for Patients During the 1st Wave of the COVID-19 in China

Who this might be right for
COVID-19Post-COVID-19 SyndromeAcute COVID-19+1 more
First Affiliated Hospital Xi'an Jiaotong University 600
Post-approval studies (Phase 4)Study completedNCT00753324
What this trial is testing

Routine Use of Antiretroviral Therapy to Prevent Mother-to-Child HIV Transmission in the Kafue District of Zambia

Who this might be right for
HIV Infections
University of North Carolina, Chapel Hill 284
Not applicableStudy completedNCT00849823
What this trial is testing

HIV Prevention Program for African American Teen Males

Who this might be right for
HIV InfectionsSexually Transmitted Infections
Richard Crosby 840
Early research (Phase 1)Study completedNCT00000879
What this trial is testing

The Effects of Giving Two Anti-HIV Vaccines to Babies of HIV-Positive Mothers

Who this might be right for
HIV InfectionsHIV Seronegativity
National Institute of Allergy and Infectious Diseases (NIAID) 48
Large-scale testing (Phase 3)Study completedNCT00708162
What this trial is testing

Multicenter, Randomized, Double-Blind, Double-Dummy, Phase 3 Study of the Safety and Efficacy of Elvitegravir Versus Raltegravir

Who this might be right for
HIV Infection
Gilead Sciences 724
Testing effectiveness (Phase 2)Active Not RecruitingNCT02797470
What this trial is testing

Gene Therapy in Treating Patients With Human Immunodeficiency Virus-Related Lymphoma Receiving Stem Cell Transplant

Who this might be right for
HIV InfectionMature T-Cell and NK-Cell Non-Hodgkin LymphomaPlasmablastic Lymphoma+8 more
AIDS Malignancy Consortium 11
Not applicableUnknownNCT00599573
What this trial is testing

Pharmacotherapy for HIV+ Stimulant Dependent Individuals

Who this might be right for
HIV InfectionsCocaine Dependence
University of Virginia 12
Not applicableStudy completedNCT04318210
What this trial is testing

Open Label Extension (OLE) of the TDF2 Study, Botswana

Who this might be right for
HIV Infections
Centers for Disease Control and Prevention 229
Testing effectiveness (Phase 2)Ended earlyNCT03198559
What this trial is testing

Combination Latency Reversal With High Dose Disulfiram Plus Vorinostat in HIV-infected Individuals on ART

Who this might be right for
HIV Infections
University of Melbourne 5
Not applicableLooking for participantsNCT05127980
What this trial is testing

Occurrence of Antibodies Cross-reacting With Autoantigens in Primary EBV Infection

Who this might be right for
Epstein-Barr Virus (EBV) Infection
University Hospital, Basel, Switzerland 80
Not applicableUnknownNCT05015062
What this trial is testing

Effectiveness of a Mobile-based HIV Prevention Intervention Involving Incentive Policy for Doctors in Liangshan, China

Who this might be right for
HIV/AIDS
Peking University 4,000
Testing effectiveness (Phase 2)Study completedNCT02038842
What this trial is testing

Immunogenicity and Safety of 4 Prime-boost Combinations of HIV Vaccine Candidates in Healthy Volunteers

Who this might be right for
HIV Infection
ANRS, Emerging Infectious Diseases 92
Large-scale testing (Phase 3)Ended earlyNCT00427297
What this trial is testing

Optimizing Pediatric HIV-1 Treatment in Infants With Prophylactic Exposure to Nevirapine, Nairobi, Kenya

Who this might be right for
HIV Infections
University of Washington 34
Large-scale testing (Phase 3)Study completedNCT00780260
What this trial is testing

Case Management Alternatives for African American Women at High Risk for HIV

Who this might be right for
HIV
Nova Southeastern University 562
Next Page